These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 33050066
1. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters. Kim S, Kim DK, Shin Y, Jeon JH, Song IS, Lee HS. Molecules; 2020 Oct 08; 25(19):. PubMed ID: 33050066 [Abstract] [Full Text] [Related]
2. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters. Kim S, Choi WG, Kwon M, Lee S, Cho YY, Lee JY, Kang HC, Song IS, Lee HS. Molecules; 2019 Aug 19; 24(16):. PubMed ID: 31430908 [Abstract] [Full Text] [Related]
3. Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters. Park EJ, Park R, Jeon JH, Cho YY, Lee JY, Kang HC, Song IS, Lee HS. Pharmaceutics; 2020 Oct 29; 12(11):. PubMed ID: 33138123 [Abstract] [Full Text] [Related]
4. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions. Liu S, Wang Z, Chan E, Zhao Y, Kang J, Zhang X, Tian X. Chem Biol Interact; 2022 Jan 25; 352():109775. PubMed ID: 34910929 [Abstract] [Full Text] [Related]
5. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes. Kong TY, Kim JH, Kwon SS, Cheong JC, Kim HS, In MK, Lee HS. Arch Pharm Res; 2017 Jun 25; 40(6):727-735. PubMed ID: 28484907 [Abstract] [Full Text] [Related]
8. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Kim JH, Kwon SS, Kong TY, Cheong JC, Kim HS, In MK, Lee HS. Molecules; 2017 Mar 10; 22(3):. PubMed ID: 28287454 [Abstract] [Full Text] [Related]
9. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides. Kazmi F, Yerino P, McCoy C, Parkinson A, Buckley DB, Ogilvie BW. Drug Metab Dispos; 2018 Aug 10; 46(8):1066-1074. PubMed ID: 29735754 [Abstract] [Full Text] [Related]
12. Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes. Choi WG, Park R, Kim DK, Shin Y, Cho YY, Lee HS. Pharmaceutics; 2020 Mar 02; 12(3):. PubMed ID: 32131538 [Abstract] [Full Text] [Related]
13. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases. Jin SE, Seo CS, Shin HK, Ha H. Pharmacogn Mag; 2016 Mar 02; 12(48):241-252. PubMed ID: 27867264 [Abstract] [Full Text] [Related]
14. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Drug Metab Dispos; 2021 Dec 02; 49(12):1070-1080. PubMed ID: 34493602 [Abstract] [Full Text] [Related]
16. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide. Jeong HU, Kwon M, Lee Y, Yoo JS, Shin DH, Song IS, Lee HS. Drug Des Devel Ther; 2015 Dec 02; 9():643-53. PubMed ID: 25653502 [Abstract] [Full Text] [Related]
18. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters. Chu X, Cai X, Cui D, Tang C, Ghosal A, Chan G, Green MD, Kuo Y, Liang Y, Maciolek CM, Palamanda J, Evers R, Prueksaritanont T. Drug Metab Dispos; 2013 Mar 02; 41(3):668-81. PubMed ID: 23293300 [Abstract] [Full Text] [Related]
19. The potential of Sutherlandia frutescens for herb-drug interaction. Fasinu PS, Gutmann H, Schiller H, James AD, Bouic PJ, Rosenkranz B. Drug Metab Dispos; 2013 Feb 02; 41(2):488-97. PubMed ID: 23209194 [Abstract] [Full Text] [Related]
20. In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin. Mamidi RNVS, Dallas S, Sensenhauser C, Lim HK, Scheers E, Verboven P, Cuyckens F, Leclercq L, Evans DC, Kelley MF, Johnson MD, Snoeys J. Br J Clin Pharmacol; 2017 May 02; 83(5):1082-1096. PubMed ID: 27862160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]